Intermolecular (IMI) Misses Q3 EPS by 2c

Intermolecular (NASDAQ: IMI) reported Q3 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $11.2 million.

Intermolecular sees Q4 2015 EPS of ($0.06)-($0.08), versus the consensus of ($0.07). Intermolecular sees Q4 2015 revenue of $12-13 million, versus the consensus of $12.2 million.

"I am happy with the results of our third quarter, as we continue to move forward with new customers in the major areas that we believe are key to Intermolecular’s future growth and profitability,” stated Bruce McWilliams, President and CEO of Intermolecular. “Our new business model is resonating with customers, and the tangible results of this approach are reflected in the strong 21% quarter over quarter program revenue growth we had in the third quarter. Our growing confidence in our new product offerings is reflected in our outlook for the fourth quarter of this year.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c